Fluorescent dye to find early food pipe changes in Barrett patients
Part of Cancer clinical trials.
This study tests a new dye that helps doctors see abnormal changes in the food pipe during a routine scope. It may help catch early signs of cancer in people with Barrett's esophagus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Barrett's esophagus, esophageal dysplasia, or early-stage esophageal cancer.
- You are having a gastroscopy (a scope test for your food pipe) at the University Medical Center Groningen.
- You are able to give written consent to take part.
- You do not have a wheat allergy, celiac disease, or dermatitis herpetiformis (a skin reaction to gluten).
- You are not pregnant or breastfeeding (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with Barrett's esophagus who are about to have a procedure to remove a suspicious spot. It tests a new way to predict if cancer might come back, and it checks how learning your risk affects your worry and quality of life.
This trial tests whether a special dye (indocyanine green) given through a vein can help doctors see the exact edges and depth of early-stage esophageal or stomach cancer during a minimally invasive procedure to remove it. If you are scheduled for this procedure, the dye may help the surgeon remove the cancer more precisely.
This Phase 2 study uses special drug dyes (bevacizumab and cetuximab, each tagged for imaging) during an esophagus scope to help doctors find very early abnormal cells, like low- or high-grade pre-cancer and superficial cancer. If you qualify, the goal is earlier detection and better targeting during diagnosis and treatment.
This study compares two ways of taking tissue samples during endoscopy to check how Barrett’s esophagus is changing. The goal is to improve surveillance, especially for finding early precancer or early cancer changes.
This study tests a special dye/light method during surgery for laryngeal and hypopharyngeal squamous cell cancer. The goal is to see if it’s safe and practical to help surgeons find the tumor more clearly.
This trial tests if a capsule-sponge device can replace endoscopy for monitoring people with ultralong-segment Barrett's esophagus. It aims to make surveillance easier and less invasive.
Hear when a new Barrett Esophagus Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.